American Marconi Wireless News

New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamineGranting of Suitability Petition enables re-filing of Abbreviated New Drug Application (ANDA) for NRx's patent-pending preservative-free ketamine product

New to The Street's Esteemed Client Aeries Technology Announces Major Enterprise Client Expansion, Projected to Reach $12M+ Annualized Run-Rate by Fiscal Year-End

Expanded, multi-function engagement validates September 4 growth plan and strengthens recurring revenue trajectory

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition

Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the significant responder analysis results for crofelemer in the prespecified subgroup of patients with breast cancer from the OnTarget study that were reported at the Multinational Association of Supportive Care in Cancer 2025 Annual Meeting and the 2024 San Antonio Breast Cancer Symposium

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / Ambience Healthcare today announced the launch of its HCC Compliance Validator. Already live with eight healthcare organizations, the HCC Compliance Validator is a real-time tool that checks whether clinician-selected diagnoses are fully substantiated according to CMS documentation standards. The tool then identifies gaps in documentation for clinicians to address before notes are completed, helping clinicians prepare audit-ready notes.

CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth

CHEYENNE, WY / ACCESS Newswire / September 24, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) ("CSDX" or "the Company"), a pioneering leader in innovative diagnostic and protective solutions, today announced a series of transformative advancements as it resumes full-scale operations. With groundbreaking progress on its flagship products, CS-Protect Hydrogel and MEDUSA, alongside a strategic capital raise and enhanced financial reporting, CSDX is poised to capture significant market share in the U.S. and international arenas.

Medical Care Technologies Inc. Unveils AI Facial Analysis for Early Diabetes Detection

MESA, ARIZONA / ACCESS Newswire / September 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in diabetes detection with its AI Facial Health Risk Estimator.

Who Is the Best Facial Feminization Surgeon in the U.S.?

Dr. Javad Sajan at Allure Esthetic is the best facial feminization surgeon in the U.S.

Wellgistics Health Launches Capital Access Program for 6,500+ Pharmacies and Supply Chain Partners, Unlocking up to $1M in Working Capital

In partnership with RxERP Financial, the program offers up to $350,000 per pharmacy and $1 million per wholesaler or manufacturer through trusted third-party financing partners, strengthening cash flow and supply chain resilience.

Medicus Pharma Ltd. To Present at Brookline Capital Markets

The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC) and development of Teverelix, a next generation GnRH Antagonist as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate CancerD-MNA and Teverelix collectively represent ~$8 billion in potential market opportunity

Congress Trying to Limit Marijuana Rescheduling, but DEA Can Still Act Now

Administrator Cole, you can fight illicit drugs and build a lawful, GMP-grade cannabinoid supply chain that shrinks the black market through science. Approve qualified marijuana manufacturers and research investigators now. Patients are waiting.

Claudia Cardinale: single mother who survived rape to be a screen queen

Sixties screen siren Claudia Cardinale, who died on Tuesday aged 87, entranced audiences across the globe with the sultry gaze that made her the muse of Luchino Visconti and Federico Fellini.

Four years in prison for woman who plotted to sell Elvis's Graceland

A Missouri woman was sentenced to more than four years in prison on Tuesday for an outlandish plot to steal ownership of Graceland, the historic home of Elvis Presley, from the family of the King of Rock and Roll and put it up for auction.

Turkey facing worst drought in over 50 years

Turkey is experiencing its worst drought in over half a century, with rainfall dropping by 27 percent compared to the last three decades and even more in some regions, according to data published this week.

Denmark brands mystery drone flights 'serious' attack

Large drones that flew over Copenhagen airport for hours and caused it to shut down constituted the "most serious attack on Danish critical infrastructure" to date, Prime Minister Mette Frederiksen said Tuesday.

Drone flights 'most serious attack' on Danish infrastructure, PM says

Large drones that flew over Copenhagen airport for hours and caused it to shut down constituted the "most serious attack on Danish critical infrastructure" to date, Prime Minister Mette Frederiksen said Tuesday.

India bids tearful farewell to maverick musician

Tens of thousands of mourners thronged the streets of India's northeastern Assam state on Tuesday to bid farewell to a flamboyant artiste, celebrated as much for his music as for his irreverent persona.

Unification Church leader arrested in South Korea

The Unification Church leader was arrested Tuesday in South Korea over allegations of bribery linked to a former first lady, including luxury gifts, prosecutors said.

LiberNovo North American Pre-Sales Now Live With the First Dynamic Ergonomic Chair

From September 23 at 7:00 PM PDT through October 20, U.S. and Canadian customers can reserve Omni with an exclusive 5% new-customer discount (limited quantities) and receive a complimentary gift pack: eye mask, eco-bag, and foot cushion. Shipping begins October 20.

Viemed Healthcare Announces Completion of Share Repurchase Program

LAFAYETTE, LA / ACCESS Newswire / September 23, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it has completed all repurchases authorized under its previously announced share repurchase program.

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

Full year fiscal 2025 net revenue of $66.4 millionFull year fiscal 2025 net loss of $13.6 millionFull year fiscal 2025 adjusted EBITDA1 of $9.2 million$31.0 million cash balance at June 30, 2025Exclusive agreement in June 2025 to commercialize EXXUA™ (gepirone) extended-release tablets ("EXXUA") is expected to serve as a major growth catalyst; the Company anticipates launching EXXUA in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") market with what the Company believes to be a novel first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDDCompany to host conference call and webcast today, September 23, 2025, at 4:30 p.m. Eastern time

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025

HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2025.

Brag House and New to The Street Exploring Strategic Collaboration

NEW YORK, NY / ACCESS Newswire / September 23, 2025 / New to The Street, one of the fastest-growing financial media brands with over 3.5 million YouTube subscribers and weekly national broadcasts on Fox Business and Bloomberg, announced today it is in discussions with Brag House, a Gen Z engagement platform operating at the intersection of gaming, college sports, and digital media, to explore a potential strategic collaboration.

Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions

BOSTON, MA / ACCESS Newswire / September 23, 2025 / MEDevice Boston, the premier MedTech event connecting top OEMs (Original Equipment Manufacturers) with emerging suppliers and strategic partners, has announced its lineup of distinguished keynote speakers for the 2025 conference. The event will take place September 30 - October 1, at the Boston Convention & Exhibition Center (BCEC). This year's keynote sessions will feature prominent thought leaders in healthcare advancements and device development, sharing insights on the future of MedTech and strategies for success in an evolving healthcare landscape.

42WEST, a Subsidiary of Dolphin, Drives Global Reveal of 30 Ninjas' Asteroid – Backed by Google's Android XR and CAA

Directed by Doug Liman, the Film Premiered in the Venice Immersive Competition at the 82nd Venice International Film Festival

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts

SAN FRANCISCO, CA / ACCESS Newswire / September 23, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, September 25, 2025 at the Emerging Growth Conference and virtually on Tuesday, September 30, 2025 at the Lytham Partners Fall 2025 Conference.

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

STONY BROOK, NY / ACCESS Newswire / September 23, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, announced that members of its business development and technical teams will be in attendance at upcoming industry conferences and present posters that underscore the Company's flexible nucleic acid production solutions designed to meet critical unmet needs for the manufacture of advanced biotherapeutics:

Medical Care Technologies Inc. Introduces AI Facial Health Risk Estimator for Cardiovascular Disease Detection

MESA, ARIZONA / ACCESS Newswire / September 23, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the launch of its AI Facial Health Risk Estimator, a groundbreaking technology that leverages advanced facial imaging to provide early risk detection for cardiovascular disease, one of the leading causes of death worldwide.

Nepra Foods Inc. Announces Exclusive North American Distribution Agreement for Award-Winning Naki Manuka Honey

VANCOUVER, BC / ACCESS Newswire / September 23, 2025 / Nepra Foods Inc. (CSE:NPRA)(OTCQB:NPRFF)(FSE:2P6) ("Nepra" or the "Company"), a pioneer in specialty and allergen-free food innovations driving healthier futures, announces an exclusive agreement between Nepra Foods Ltd. and Naki New Zealand, a premier family-owned producer of Unique Manuka Factor (UMF) certified Manuka honey. This strategic partnership positions Nepra as the sole North American distributor and sales team for Naki's Manuka honey products starting in Q4 2025. Further contract details remain confidential.

Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groupsBoth of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains

CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities

Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies

Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay

First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients

Viromed Medical AG initiates approval process for PulmoPlas(R) with the Federal Institute for Drugs and Medical Devices (BfArM)

RELLINGEN, DE / ACCESS Newswire / September 23, 2025 / Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, has initiated the official approval process for its new product PulmoPlas® with the Federal Institute for Drugs and Medical Devices („Bundesinstitut für Arzneimittel und Medizinprodukte"; BfArM). With this step, the company is setting the course for the future widespread use of this novel therapy.

RBGPF	0%	78.22	$
CMSC	-0.29%	23.87	$
SCS	-0.06%	17.21	$
NGG	1.23%	73.43	$
RYCEF	0.51%	15.76	$
GSK	-0.78%	43.35	$
AZN	1.95%	85.31	$
BTI	-0.7%	51.24	$
BP	0.88%	34.16	$
RELX	-0.43%	46.41	$
RIO	-0.23%	66.11	$
CMSD	0.25%	24.45	$
BCE	0.56%	23.36	$
JRI	0.21%	14.3	$
BCC	-0.53%	77.63	$
VOD	-0.53%	11.36	$

American Marconi Wireless News - Boulevard (English)

Featured

Death toll from Indonesia school collapse rises to 37

Georgia ruling party wins local polls as mass protests flare

Last news